模拟目标试验的观察性研究的透明报告:TARGET声明
TARGET声明由EQUATOR框架指导制定,通过系统综述、两轮在线调查(2023年8月至2024年3月,来自6个国家的18名专家参与)、为期3天的专家共识会议(2024年6月,18名专家组成员参与)以及对草案清单的利益相关者试点(n=108,2024年9月至2025年2月)形成。最终清单共21个条目,分为6个部分,为通过明确模拟平行组、个体随机化目标试验并校正基线混杂因素的干预性观察研究提供报告指导。
要点
- TARGET清单含21个条目,分为摘要、引言、方法、结果、讨论和其他信息6个部分。
- 适用于明确模拟平行组、个体随机化目标试验并校正基线混杂因素的干预性观察研究。
- 核心推荐包括:标明研究为模拟目标试验、说明因果问题与模拟理由、明确目标试验方案及其与观察数据的映射、报告各因果估计值及其精度和敏感性分析结果。
核心结论
- 应用TARGET指南推荐旨在提高报告透明度与同行评审质量,并帮助研究者、临床医生及其他读者解读和应用研究结果。
研究设计与样本
- TARGET指南依据EQUATOR框架制定,制定过程包括:对明确模拟目标试验的已发表研究的报告实践进行系统综述;开展两轮在线调查(2023年8月至2024年3月,来自6个国家的18名专家参与);举行为期3天的专家共识会议(2024年6月,18名专家组成员参与);以及对草案清单开展利益相关者试点(n=108,2024年9月至2025年2月)。
主要发现
- 最终形成的TARGET清单共21个条目,分为6个部分:摘要、引言、方法、结果、讨论和其他信息。
- TARGET为明确模拟平行组、个体随机化目标试验并校正基线混杂因素的干预性观察研究提供报告指导。
关键数值与推荐
- 关键推荐包括:标明研究为模拟目标试验的观察性研究。
- 关键推荐包括:概述因果问题及模拟目标试验的理由。
- 关键推荐包括:清晰说明目标试验方案(即因果估计目标、识别假设、数据分析计划)以及如何将其映射到观察数据。
- 关键推荐包括:报告每个因果估计目标所获得的估计值及其精度,以及评估估计值对假设、设计和分析选择敏感性的额外分析结果。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: When randomized trials are unavailable or not feasible, observational studies can be used to answer causal questions about the comparative effects of interventions by attempting to emulate a hypothetical pragmatic randomized trial (target trial). Published guidance to aid reporting of these studies is not available. OBJECTIVE: To develop consensus-based guidance for reporting observational studies performed to estimate causal effects by explicitly emulating a target trial. DESIGN, SETTING, AND PARTICIPANTS: The Transparent Reporting of Observational Studies Emulating a Target Trial (TARGET) guideline was developed using the Enhancing the Quality and Transparency of Health Research (EQUATOR) framework. The development included (1) a systematic review of reporting practices in published studies that had explicitly aimed to emulate a target trial; (2) a 2-round online survey (August 2023 to March 2024; 18 expert participants from 6 countries) to assess the importance of candidate items selected from previous research and to identify additional items; (3) a 3-day expert consensus meeting (June 2024; 18 panelists) to refine the scope of the guideline and draft the checklist; and (4) pilot of the draft checklist with stakeholders (n = 108; September 2024 to February 2025). The checklist was further refined based on feedback on successive drafts. FINDINGS: The 21-item TARGET checklist is organized into 6 sections (abstract, introduction, methods, results, discussion, other information). TARGET provides guidance for reporting observational studies of interventions explicitly emulating a parallel group, individually randomized target trial, with adjustment for baseline confounders. Key recommendations are to (1) identify the study as an observational emulation of a target trial; (2) summarize the causal question and reason for emulating a target trial, (3) clearly specify the target trial protocol (ie, the causal estimand, identifying assumptions, data analysis plan) and how it was mapped to the observational data, and (4) report the estimate obtained for each causal estimand, its precision, and findings from additional analyses to assess the sensitivity of the estimates to assumptions, and design and analysis choices. CONCLUSIONS AND RELEVANCE: Application of the TARGET guideline recommendations aims to improve reporting transparency and peer review and help researchers, clinicians, and other readers interpret and apply the results.
引用
- Cashin AG, Hansford HJ, Hernán MA, et al. Transparent Reporting of Observational Studies Emulating a Target Trial-The TARGET Statement. JAMA. 2025. PMID: 40899949. doi:10.1001/jama.2025.13350
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。